Submitted:
03 October 2024
Posted:
04 October 2024
You are already at the latest version
Abstract
Keywords:
Introduction
Methods
Study Design and Setting
Population and Sampling
Data Analysis
Results
Demographic Characteristics
Geographic Distribution
Bacterial Culture Results
Statistical Analysis
| Category | Subcategory | Frequency | Percent | Valid Percent | Cumulative Percent |
|---|---|---|---|---|---|
| Sample Type | Urine | 333 | 98.8 | ||
| Blood | 1 | 0.3 | |||
| Both Blood and Urine | 3 | 0.9 | |||
| Total | 337 | 100.0 | |||
| Leucocytes | <750000 | 118 | 65.9 | ||
| 750000+ | 61 | 34.1 | |||
| Total | 179 | 100.0 | |||
| Erythrocytes | <750000 | 58 | 31.7 | ||
| 750000+ | 125 | 68.3 | |||
| Total | 183 | 100.0 | |||
| Epithelial cells | 1+ | 65 | 34.6 | ||
| 2+ (Moderate) | 15 | 8.0 | |||
| 3+ (Numerous) | 9 | 4.8 | |||
| Not Observed | 99 | 52.7 | |||
| Total | 188 | 100.0 | |||
| Casts | Casts Present | 45 | 23.9 | ||
| Not Observed | 143 | 76.1 | |||
| Total | 188 | 100.0 | |||
| Crystals | Crystals Present | 14 | 4.2 | 100.0 | 100.0 |
| Missing | 323 | 95.8 | |||
| Total | 337 | 100.0 | |||
| Parasite | Parasite Present | 8 | 88.9 | ||
| Not Observed | 1 | 11.1 | |||
| Total | 9 | 100.0 | |||
| Schistosoma Haematobium ova | Viable ova observed | 331 | 98.2 | ||
| No ova observed | 6 | 1.8 | |||
| Total | 337 | 100.0 | |||
| Antimicrobial Substances | Present | 117 | 46.4 | ||
| Absent | 135 | 53.6 | |||
| Total | 252 | 100.0 | |||
| Erythrocytes during Ova Exam | 1+ | 12 | 5.3 | ||
| 2+ (Moderate) | 19 | 8.4 | |||
| 3+ (Numerous) | 193 | 85.4 | |||
| Not Observed | 2 | 0.9 | |||
| Total | 226 | 100.0 | |||
| Sensitivity Status | Sensitive to one Antibiotics | 40 | 87.0 | ||
| Sensitive to two Antibiotics | 4 | 8.7 | |||
| Sensitive to three Antibiotics | 2 | 4.3 | |||
| Total | 46 | 100.0 |


Discussion
Antimicrobial Substances and Sensitivity Status
The Implications of This Research
Public Health Improvement
Policy Development
Community Awareness and Education
Economic Impact
Future Research
Global Health Contributions
Conclusion
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgements
Conflicts of Interest
References
- Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014). Human schistosomiasis. The Lancet, 383(9936), 2253-2264. [CrossRef]
- Karunamoorthi, K., Almalki, M. J., & Ghailan, K. Y. (2018). Schistosomiasis: A neglected tropical disease of poverty: A call for intersectoral mitigation strategies for better health. Journal of Health Research and Reviews (In Developing Countries), 5(1), 1-12. [CrossRef]
- Adenowo, A. F., Oyinloye, B. E., Ogunyinka, B. I., & Kappo, A. P. (2015). Impact of human schistosomiasis in sub-Saharan Africa. Brazilian Journal of Infectious Diseases, 19(2), 196-205. [CrossRef]
- Mawa, P. A., Kincaid-Smith, J., Tukahebwa, E. M., Webster, J. P., & Wilson, S. (2021). Schistosomiasis morbidity hotspots: roles of the human host, the parasite and their interface in the development of severe morbidity. Frontiers in immunology, 12, 635869. [CrossRef]
- Adekiya, T. A., Aruleba, R. T., Oyinloye, B. E., Okosun, K. O., & Kappo, A. P. (2020). The effect of climate change and the snail-schistosome cycle in transmission and bio-control of schistosomiasis in Sub-Saharan Africa. International journal of environmental research and public health, 17(1), 181. [CrossRef]
- Nelwan, M. L. (2019). Schistosomiasis: life cycle, diagnosis, and control. Current Therapeutic Research, 91, 5-9. [CrossRef]
- Gray, D. J., Ross, A. G., Li, Y. S., & McManus, D. P. (2011). Diagnosis and management of schistosomiasis. Bmj, 342. [CrossRef]
- Magaisa, K., Taylor, M., Kjetland, E. F., & Naidoo, P. J. (2015). A review of the control of schistosomiasis in South Africa. South African Journal of Science, 111(11-12), 1-6. [CrossRef]
- Adewale, B., Mafe, M. A., Mogaji, H. O., Balogun, J. B., Sulyman, M. A., Ajayi, M. B., ... & Balogun, E. O. (2024). Urinary schistosomiasis and anemia among school-aged children from southwestern Nigeria. Pathogens and Global Health, 1-9. [CrossRef]
- World Health Organization. (2022). Schistosomiasis and soil-transmitted helminthiases: progress report, 2021. Weekly epidemiological record, 48(97), 621-632.
- Li, Q., Li, Y. L., Guo, S. Y., Li, S. Z., Wang, Q., Lin, W. N., ... & Xu, J. (2024). Schistosomiasis in Humans, 1990-2041: Findings from the Global Burden of Disease 2021 Study and Predictions by Bayesian Age-Period-Cohort Analysis. medRxiv, 2024-06. [CrossRef]
- Sacolo, H., Chimbari, M., & Kalinda, C. (2018). Knowledge, attitudes and practices on Schistosomiasis in sub-Saharan Africa: a systematic review. BMC infectious diseases, 18, 1-17. [CrossRef]
- Díaz, A. V., Walker, M., & Webster, J. P. (2023). Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective. Philosophical Transactions of the Royal Society B, 378(1887), 20220274. [CrossRef]
- Aribodor, O. B., Azugo, N. O., Jacob, E. C., Ngenegbo, U. C., Onwusulu, N. D., Obika, I., ... & Nebe, O. J. (2024). Assessing urogenital schistosomiasis and female genital schistosomiasis (FGS) among adolescents in Anaocha, Anambra State, Nigeria: implications for ongoing control efforts. BMC Public Health, 24(1), 952. [CrossRef]
- Gebrehana, D. A., Molla, G. E., Endalew, W., Teshome, D. F., Mekonnen, F. A., & Angaw, D. A. (2024). Prevalence of schistosomiasis and its association with anemia in Ethiopia, 2024: a systematic review and meta-analysis. BMC Infectious Diseases, 24(1), 1-15. [CrossRef]
- Klohe, K., Koudou, B. G., Fenwick, A., Fleming, F., Garba, A., Gouvras, A., ... & Rollinson, D. (2021). A systematic literature review of schistosomiasis in urban and peri-urban settings. PLOS Neglected Tropical Diseases, 15(2), e0008995. [CrossRef]
- De Boni, L., Msimang, V., De Voux, A., & Frean, J. (2021). Trends in the prevalence of microscopically-confirmed schistosomiasis in the South African public health sector, 2011–2018. PLoS Neglected Tropical Diseases, 15(9), e0009669. [CrossRef]
- Shams, M., Khazaei, S., Ghasemi, E., Nazari, N., Javanmardi, E., Majidiani, H., ... & Asghari, A. (2022). Prevalence of urinary schistosomiasis in women: a systematic review and meta-analysis of recently published literature (2016–2020). Tropical Medicine and Health, 50(1), 12. [CrossRef]
| Category | Subcategory | Frequency | Valid Percent |
|---|---|---|---|
| Patient Age Group | <10 | 81 | 24.9 |
| 10-19 | 206 | 63.4 | |
| 20+ | 50 | 11.7 | |
| Total | 337 | 100.0 | |
| Patient Gender | Male | 243 | 76.4 |
| Female | 94 | 23.6 | |
| Total | 337 | 100.0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).